A discussion on Fed rate cuts and Q4 outlook highlighted the positive market response. Insights on sectors' performance, upcoming economic data, and market strategist views were shared. Allogene Therapeutics, Inc. was reviewed as a rising penny stock with promising cancer treatments.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing